This inventor holds 1 USPTO granted patent. Top assignee: The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2009.
Company Filing History:
Years Active: 2009
Title: Inventor Spotlight: Ruth S. Rappaport
Introduction
Ruth S. Rappaport, an innovative inventor based in Strafford, PA, has made significant contributions to the field of biotechnology. With a focus on vaccine development, she is known for her work in the analysis of rotavirus vaccines, particularly through her patented technology. This article explores her latest patent, career highlights, and collaborations in the field.
Latest Patents
Rappaport holds a patent for the "Sequence analysis of the tetravalent rotavirus vaccine." This patent involves isolated nucleic acid molecules comprising a gene segment from rhesus rotavirus or human reassortant viruses. The technology includes isolated nucleic acid molecules with sequences designated as SEQ ID NO: 1-14 and variants encoding proteins with sequences SEQ ID NO: 15-28. This innovative work is crucial in the advancement of effective rotavirus vaccines.
Career Highlights
Ruth S. Rappaport is associated with the United States of America, represented by the Secretary of the Department of Health and Human Services. Her dedication to biotechnology and vaccine research has earned her recognition in the field, underscoring her role as a pivotal inventor in public health initiatives.
Collaborations
Throughout her career, Rappaport has collaborated with esteemed colleagues such as Deborah A. Buonagurio and Alice F. Georgiu. These collaborations enable further development and enhancement of vaccine technologies, demonstrating the importance of teamwork in scientific research.
Conclusion
Ruth S. Rappaport’s contributions to vaccine development through her patented technology exemplify the vital work being done in the field of biotechnology. Her career and collaborations underscore her commitment to improving public health and advancing scientific knowledge. As an inventor, her innovative spirit continues to inspire future developments in vaccine research.